Related Experiment Video
Updated: May 12, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
Published on: August 11, 2023
Infectious complications of ANCA-associated vasculitis: Description and associated outcome
Jeanne Morin1, Pierre-André Jarrot2, Justine Solignac3
1Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Introduction:
In ANCA-associated vasculitis (AAV), both the disease and its treatments contribute to systemic complications, among which, infections represent a major cause of morbidity and mortality. This study aimed to evaluate the prevalence and prognosis of infectious complications in AAV, to identify associated risk factors, and to describe long-term outcomes.
Methods:
This retrospective monocentric study included patients followed in the Nephrology and Internal Medicine departments at Conception Hospital after a first episode or relapse of AAV between 2004 and 2024. Infection was considered if requiring hospitalization or an anti-infectious therapy. Follow-up was conducted until January 1st, 2025.
Results:
Among 264 patients included, the incidence of infection was 43.9%, with respiratory infections accounting for 49.1% of cases and bacterial infections for 75.3%, mainly with gram negative bacillus. Infection episodes were significantly associated with age >65 years (p =0.02), hypertension (p=0.04), diabetes (p =0.01), a high Five-Factor Score (p =0.005), a high BVAS (p =0.03), anti-PR3 positivity (p =0.03), acute kidney injury (p=0.004), cyclophosphamide (p =0.05), and intravenous corticosteroid for induction (p =0.03). In multivariate analysis, anti-PR3 positivity (aOR = 2.0, p=0.03) was independent risk factors, whereas methotrexate appeared protective (aOR = 0.08, p=0.001). Infections were independently linked to vasculitis relapses (aOR = 2.8, p=0.007) and cardiovascular events (aOR 3.0, p =0.01). Survival analysis demonstrated a significant association between mortality and infection (HR 2.14 95%CI[1.59-2.91], p<0.001).
Conclusion:
Infections are frequent complications in AAV, and exert an independent impact on mortality. Anti-PR3 positivity increases infection risk, whereas methotrexate appears protective.
Insights
Infections are common in ANCA-associated vasculitis (AAV) and increase mortality risk. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis patients with anti-PR3 positivity face higher infection risks, while methotrexate shows a protective effect.
Area of Science:
- Nephrology
- Internal Medicine
- Rheumatology
Background:
- Systemic complications, particularly infections, are significant causes of morbidity and mortality in ANCA-associated vasculitis (AAV).
- Both the disease itself and its treatments contribute to these complications.
Purpose of the Study:
- To evaluate the prevalence and prognosis of infectious complications in AAV.
- To identify risk factors associated with infections in AAV patients.
- To describe the long-term outcomes of infectious complications in AAV.
Main Methods:
- Retrospective monocentric study including 264 patients with AAV.
- Infection defined as requiring hospitalization or anti-infectious therapy.
- Follow-up conducted until January 1st, 2025.
Main Results:
- Infection incidence was 43.9%, with respiratory infections (49.1%) and bacterial infections (75.3%) being most common.
- Risk factors included age >65, hypertension, diabetes, high Five-Factor Score, high BVAS, anti-PR3 positivity, acute kidney injury, cyclophosphamide, and intravenous corticosteroids.
- Anti-PR3 positivity was an independent risk factor (aOR=2.0), while methotrexate was protective (aOR=0.08). Infections were linked to relapses (aOR=2.8) and cardiovascular events (aOR=3.0).
- Mortality was significantly associated with infection (HR=2.14).
Conclusions:
- Infections are frequent in AAV and independently impact mortality.
- Anti-PR3 positivity is associated with increased infection risk.
- Methotrexate demonstrates a protective effect against infections in AAV.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Aneurysm III: Interprofessional Care
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction

